Anavex Life Sciences Corp (AVXL)

[TempePhil]

Georgej, continuing your AnavexA2-73 vs SavaSimufilam comparison. Regarding your 110:8 Sigmar1:filaminA ratio of papers:
The integrity of 3 of those 8 filaminA papers are being disputed (see eliesbik's "Cassava Sciences: Of stocks and blots" at scienceintegritydigest.com). Two of those papers in dispute are all about Sava's biomarkers.

The Sava proponents say that the legal problems have only to do with the biomarker data.

While doing counts...Sava's latest slide deck (CASSAVADeck(Sept2021)b) has four slides dedicated to their biomarker findings, with only 1 dedicated to cognition findings. Which one is the beef?
I have only been able to find terse cognition top line data from Sava. No details published. FYI Peter Karol did some analysis of Anavex 2-73 and Simufilam.

Sava's Simufilam may yet prove therapeutic, but the questions have not been answered. Interesting to watch.